Abstract
Coronary artery disease (CAD), a significant health problem and global burden is a leading cause of disability and death worldwide 1. In developing countries, CAD-related deaths were estimated to be as high as 17.5 million in 2005 and are further expected to increase by 137% in males and 120% in females by 2020 2. Patients with CAD are typically asymptomatic initially, and major adverse cardiovascular events (MACEs) are more likely to occur in those presenting with severe CAD and significant clinical conditions, including myocardial infarction (MI), cardiac arrest, stroke, or death from cardiovascular (CV) events 3. Therefore, it is important to identify biomarkers that may be early indicators of CAD or MACEs and further strengthening preventive strategies.
[mks_button size=”large” title=”Download PDF” style=”squared” url=”https://clinicalhealthjournal.com/wp-content/uploads/2020/09/High-Serum-Angiopoietin-Like-Protein-3-Levels-Associated.pdf” target=”_self” bg_color=”#000000″ txt_color=”#FFFFFF” icon=”” icon_type=”” nofollow=”0″]
High-Serum-Angiopoietin-Like-Protein-3-Levels-Associated
